Skip to main content
. 2021 Dec 17;5(24):5490–5500. doi: 10.1182/bloodadvances.2021004824

Table 2.

Impact of age, ECOG-PS, CCI, CIRS, CIRS3+ on toxicity-related discontinuation and PDR

Tox-DTD, % P PDR, % P
Age
 <65 y vs ≥65y 11 vs 19 .003 15 vs 18 .086
ECOG-PS
 0-1 vs >1 13 vs 37 <.001 16 vs 22 .020
CCI
 <2 vs ≥2 8 vs 18 .002 8 vs 18 <.001
CIRS
 ≤6 vs >6 13 vs 24 <.001 12 vs 27 <.001
CIRS3+
 No vs yes 13 vs 29 <.001 15 vs 26 <.001
Age <65 y
 CIRS ≤6 vs >6 11 vs 13 .843 14 vs 18 .537
 CIRS3+ no vs yes 9 vs 31 <.001 13 vs 29 .018
Age ≥65 y
 CIRS ≤ 6 vs >6 11 vs 26 .020 11 vs 29 <.001
 CIRS3+ no vs yes 16 vs 29 <.001 16 vs 26 .010